PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
12-Jan-2023 Growing demand for synthetic biology is driving the sales of Biotechnology Reagents & Kits Market 2023 | insightSLICE insightSLICE
12-Jan-2023 Rising prevalence of lifestyle diseases is driving the sales of Biopreservation Market 2023 | insightSLICE insightSLICE
12-Jan-2023 Rising demand for organ transplantation & tissue engineering is driving the sales of 3D Cell Culture Market 2023 | insightSLICE insightSLICE
12-Jan-2023 The Kraken wakes – new Covid variant increases the risk of ‘Longer Covid’, warns expert London Medical Laboratory
12-Jan-2023 Sanofi Ventures announces multi-year capital commitment from Sanofi, increasing evergreen fund to $750M Sanofi Ventures
12-Jan-2023 Avillion announces US approval of AstraZeneca’s Airsupra (PT027) as new rescue treatment for asthma Avillion
12-Jan-2023 Novotech Acquires European CRO – Strengthens Global Operations Novotech
12-Jan-2023 New Phesi global analysis sees breast cancer retain position as most studied disease area in 2022 Phesi
12-Jan-2023 First and only rescue medication approved in the US for as-needed use to reduce risk of asthma exacerbations AstraZeneca
12-Jan-2023 Six minutes of high-intensity exercise could delay the onset of Alzheimer’s disease The Physiological Society
12-Jan-2023 Novotech Acquires US-based Drug Development Consulting Firm, CBR International Novotech Health Holdings Pte Ltd
12-Jan-2023 Novotech Acquires European CRO, Strengthens Global Operations Novotech Health Holdings Pte Ltd
12-Jan-2023 Biophytis to take appropriate measures after receiving Nasdaq deficiency notice Biophytis
11-Jan-2023 HighTide Therapeutics Announces First Patient Dosed in Phase 2b Clinical Study Evaluating HTD1801 in NASH (the CENTRICITY study) HighTide Therapeutics Inc.
11-Jan-2023 Samsung Biologics receives the Terra Carta Seal in recognition of the company’s commitment to creating a sustainable future Samsung Biologics
11-Jan-2023 ABL SA group acquires Berlin based Medtech company Humedics ABL SA
11-Jan-2023 BioXcel Therapeutics Announces Promising Top-Line Results from Phase 2 Trial of BXCL701 in Aggressive Form of Rare Prostate Cancer BioXcel Therapeutics
11-Jan-2023 Zenas BioPharma Announces First Patient Dosed in Phase 3 Clinical Study of Obexelimab for the Treatment of Immunoglobulin G4-Related Disease (IgG4-RD) Zenas BioPharma
11-Jan-2023 UK independent clinical trial sites running research on new medicines continue to prosper despite the decline at NHS sites Panthera
11-Jan-2023 Valo Therapeutics selects Exothera to develop large-scale oncolytic adenovirus manufacturing Valo Therapeutics